Health & Safety Industry Today

Europe Precision Medicine Market is Estimated to Reach $118.79 Billion by 2034 – BIS Research

The Europe precision medicine market is evolving rapidly, integrating genomics, next-generation sequencing (NGS), AI-enabled diagnostics, and digital health platforms to deliver patient-specific treatments. Estimated at $40.75 billion in 2024, the market is projected to reach $118.79 billion by 2034, growing at a CAGR of 11.29%. Key drivers include rising cancer and chronic disease prevalence, national genomics strategies, and investments in cross-border data interoperability and AI-based imaging tools.
Published 18 July 2025

What is Precision Medicine? 

Precision medicine is a personalized approach to disease prevention, diagnosis, and treatment based on individual genetic profiles, environmental exposure, and lifestyle factors. In Europe, this translates into biomarker-driven therapy selection, AI-powered decision support, and genomics-integrated digital health systems. 

What is the Current Market Outlook for Europe Precision Medicine? 

Valued at $40.75 billion in 2024, the Europe precision medicine market is expected to grow at a CAGR of 11.29%, reaching $118.79 billion by 2034. Growth is fueled by a strong healthcare infrastructure, funding for genomics programs, and demand for targeted therapies in oncology and rare diseases. 

Request report sample on Europe Precision Medicine Market 


What are the Key Innovations & Trends in the Europe Precision Medicine Market? 


  • AI-powered diagnostics and predictive modeling 
  • Next-generation sequencing and multi-omics platforms 
  • Federated data networks and imaging repositories (e.g., Clinnova, EUCAIM) 
  • Biomarker discovery in oncology and rare diseases 
  • Expansion of national genomic databases (e.g., Genomics England, France Génomique) 


Unlock Critical Insights with Surgical Procedure Database   

Discover BIS Research Surgical Procedure Volume Database – your key to real-world, country-level procedural insights across MedTech.      

How Does This Report Help Organizations Drive Strategic Growth? 


  • Pinpoint high-growth therapeutic areas such as oncology and rare diseases 
  • Benchmark leading vendors, AI and genomics startups, and platform providers 
  • Navigate evolving regulatory frameworks and data-sharing standards 
  • Identify regional collaboration opportunities and innovation clusters 
  • Build a roadmap for integrating AI and genomics into clinical workflows 

Explore the Full TOC and Download Report Sample 


What Are the Key Demand Drivers and Challenges in the Europe Precision Medicine Market? 


Drivers: 


  • Growth in oncology, rare diseases, and chronic disease burden 
  • EU and national funding for genomic sequencing programs 
  • AI and digital platform integration into clinical workflows 


Challenges: 


  • Complex regulatory landscape across EU member states 
  • Interoperability and standardization of health/genomic data 
  • High costs associated with NGS, data storage, and precision diagnostics 

What is the Market Segmentation in the Europe Precision Medicine Market? 

by Ecosystem 

•    Applied Science 

•    Precision Diagnostics 

•     Digital Health and Information Technology 

•    Precision Therapeutics 

by Region 

•    Europe 

        o    Germany 

        o    U.K. 

        o    France 

        o    Italy 

        o    Spain 

        o    Rest-of-Europe 

Download the Complete TOC! 


What Are the Key Players in the Europe Precision Medicine Market? 

•    Almac Group Ltd.  

•    ANGLE plc 

•    F. Hoffmann-La Roche Ltd. 

•    Merck KGaA  

•    QIAGEN N.V. 


Strategic Initiatives 

Collaborations such as AstraZeneca and Sophia Genetics for AI-driven genomic analytics, EU-funded platforms like EUCAIM and Clinnova focusing on federated imaging and real-time diagnostics, and national genome sequencing efforts are enhancing Europe’s ecosystem for personalized healthcare. 

Here Are Some Case Studies and Success Stories in the Europe Precision Medicine Market 


  • Clinnova Project (2024): Launched a federated infrastructure connecting hospitals across Luxembourg, France, and Germany, enabling AI-based diagnostics for diseases like multiple sclerosis and inflammatory bowel disease. 
  • EUCAIM Initiative: Led by Spain’s La Fe Hospital and supported by Horizon Europe, it integrates imaging biobanks across Europe to accelerate AI model development and deployment for cancer detection. 


Schedule a Call with Industry Experts  


Related Reports from BIS Research  

Precision Medicine Market 

Oncology Precision Medicine Market 

Asia-Pacific Precision Medicine Software Market 


About BIS Research  

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends, which can disrupt the market dynamics in the near future. We publish over 200 market intelligence studies annually, focusing on several deep technology verticals.    

Our strategic market analysis emphasizes market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.     

BIS Research offers syndicate and custom studies and expert consultations to firms, providing them with specific and actionable insights on novel technology markets, business models, and competitive landscapes.    


Contact  

Head of Marketing   

Email: media@bisresearch.com     

BIS Research Inc.    

39111 PASEO PADRE PKWY STE 313,    

FREMONT, CA 94538-1686   


Visit our Blog @https://bisresearch.com/insights    

Get Expert Insights @https://community.insightmonk.com     

Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research     

Connect with us on Twitter@ https://twitter.com/BISResearch    

Connect with us on Medium@ https://medium.com/@faisal.bis  

Connect with us on YouTube@ https://www.youtube.com/@BISResearchInc    



Other Industry News

Ready to start publishing

Sign Up today!